![New issues: Issuer Teva Pharmaceutical Industries released international bonds (XS2592804194, US88167AAR23) in the amount of EUR 500, USD 500 mln maturing in 2031, 2031 respectively. New issues: Issuer Teva Pharmaceutical Industries released international bonds (XS2592804194, US88167AAR23) in the amount of EUR 500, USD 500 mln maturing in 2031, 2031 respectively.](https://data.cbonds.com/organisations_logos/13739/1506089713teva.png)
New issues: Issuer Teva Pharmaceutical Industries released international bonds (XS2592804194, US88167AAR23) in the amount of EUR 500, USD 500 mln maturing in 2031, 2031 respectively.
![Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets](https://ethicalmarketingnews.com/wp-content/uploads/2021/11/teva.jpg)
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets
![Teva Celebrates Pride with an Expansive Collection and Donation to the Human Rights Campaign Foundation Teva Celebrates Pride with an Expansive Collection and Donation to the Human Rights Campaign Foundation](https://mma.prnewswire.com/media/1511992/Teva_S21_1122011_W_MidformUniversalPride_BLRW_1116376_W_FlatformUniversalStripe_BRNBW_YMR_6276.jpg?p=facebook)
Teva Celebrates Pride with an Expansive Collection and Donation to the Human Rights Campaign Foundation
![Teva Issues Largest Ever Sustainability-Linked Bond Tied to Climate and Access to Medicine Goals - ESG Today Teva Issues Largest Ever Sustainability-Linked Bond Tied to Climate and Access to Medicine Goals - ESG Today](https://www.esgtoday.com/wp-content/uploads/2021/11/pharma.jpg)
Teva Issues Largest Ever Sustainability-Linked Bond Tied to Climate and Access to Medicine Goals - ESG Today
![Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology](https://media.americanpharmaceuticalreview.com/m/28/article/598684.jpg)
Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
![S&P announced it had downgraded Teva's credit rating by one level - from BB to junk bonds :: Israeli Financial News - The Israeli Economic World S&P announced it had downgraded Teva's credit rating by one level - from BB to junk bonds :: Israeli Financial News - The Israeli Economic World](https://www.ifi.today/uploads/d/dan56/tiv333_32921~.jpg)
S&P announced it had downgraded Teva's credit rating by one level - from BB to junk bonds :: Israeli Financial News - The Israeli Economic World
![Market Rover: 20 High Yield Bonds Selling-Off, These 3 Are Worth Considering — Blue Harbinger Investment Research Market Rover: 20 High Yield Bonds Selling-Off, These 3 Are Worth Considering — Blue Harbinger Investment Research](https://images.squarespace-cdn.com/content/v1/53f238bce4b0d0156e18c38a/1518901542755-UNJZB78IDIRKOJ7DDZ4M/Picture3.png)